Janney Montgomery Scott LLC Purchases 256 Shares of STERIS plc (NYSE:STE)

Janney Montgomery Scott LLC lifted its position in shares of STERIS plc (NYSE:STE) by 3.5% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,609 shares of the medical equipment provider’s stock after acquiring an additional 256 shares during the quarter. Janney Montgomery Scott LLC’s holdings in STERIS were worth $1,846,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Phillips Wealth Planners LLC increased its holdings in STERIS by 4.6% in the third quarter. Phillips Wealth Planners LLC now owns 2,512 shares of the medical equipment provider’s stock valued at $568,000 after purchasing an additional 111 shares during the last quarter. Dash Acquisitions Inc. increased its holdings in STERIS by 4.9% in the third quarter. Dash Acquisitions Inc. now owns 26,106 shares of the medical equipment provider’s stock valued at $5,851,000 after purchasing an additional 1,221 shares during the last quarter. Oak Ridge Investments LLC increased its holdings in STERIS by 6.8% in the third quarter. Oak Ridge Investments LLC now owns 25,899 shares of the medical equipment provider’s stock valued at $6,282,000 after purchasing an additional 1,644 shares during the last quarter. Deroy & Devereaux Private Investment Counsel Inc. increased its holdings in STERIS by 0.8% in the third quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 17,250 shares of the medical equipment provider’s stock valued at $4,184,000 after purchasing an additional 140 shares during the last quarter. Finally, Diversify Wealth Management LLC increased its holdings in STERIS by 7.8% in the third quarter. Diversify Wealth Management LLC now owns 4,222 shares of the medical equipment provider’s stock valued at $934,000 after purchasing an additional 304 shares during the last quarter. Institutional investors own 94.69% of the company’s stock.

Insider Buying and Selling at STERIS

In other STERIS news, CFO Michael J. Tokich sold 23,332 shares of STERIS stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $247.00, for a total transaction of $5,763,004.00. Following the completion of the transaction, the chief financial officer now owns 42,930 shares in the company, valued at approximately $10,603,710. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.14% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have issued reports on STE shares. Piper Sandler raised STERIS from a “neutral” rating to an “overweight” rating and boosted their target price for the company from $230.00 to $260.00 in a research note on Thursday, October 24th. Stephens reissued an “overweight” rating and issued a $260.00 target price on shares of STERIS in a research note on Thursday, November 7th. KeyCorp upped their price objective on STERIS from $255.00 to $265.00 and gave the stock an “overweight” rating in a research report on Tuesday, September 3rd. JMP Securities reaffirmed a “market outperform” rating and set a $265.00 price objective on shares of STERIS in a research report on Wednesday, August 7th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a research report on Friday, November 8th. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $253.00.

STERIS Stock Down 0.2 %

Shares of NYSE:STE opened at $222.23 on Thursday. The firm has a market cap of $21.94 billion, a P/E ratio of 50.74 and a beta of 0.85. The company has a quick ratio of 1.55, a current ratio of 2.41 and a debt-to-equity ratio of 0.33. STERIS plc has a 12-month low of $195.47 and a 12-month high of $248.24. The business has a fifty day simple moving average of $231.12 and a 200 day simple moving average of $228.20.

STERIS (NYSE:STE) last posted its quarterly earnings data on Wednesday, November 6th. The medical equipment provider reported $2.14 earnings per share for the quarter, topping the consensus estimate of $2.12 by $0.02. STERIS had a return on equity of 13.78% and a net margin of 8.02%. The firm had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.33 billion. During the same period last year, the company posted $2.03 EPS. The business’s quarterly revenue was up 7.3% on a year-over-year basis. Analysts predict that STERIS plc will post 9.15 earnings per share for the current year.

STERIS Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 19th. Shareholders of record on Tuesday, November 19th will be paid a dividend of $0.57 per share. The ex-dividend date is Tuesday, November 19th. This represents a $2.28 dividend on an annualized basis and a yield of 1.03%. STERIS’s dividend payout ratio (DPR) is currently 52.05%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.